table of content
1 Introduction to Research & Analysis Reports
1.1 Live Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Vaccines Overall Market Size
2.1 Global Live Vaccines Market Size: 2022 VS 2030
2.2 Global Live Vaccines Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Live Vaccines Sales: 2018-2030
3 Company Landscape
3.1 Top Live Vaccines Players in Global Market
3.2 Top Global Live Vaccines Companies Ranked by Revenue
3.3 Global Live Vaccines Revenue by Companies
3.4 Global Live Vaccines Sales by Companies
3.5 Global Live Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Live Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Vaccines Market Size Markets, 2022 & 2030
4.1.2 Monovalent Live Vaccines
4.1.3 Multivalent Live Vaccines
4.2 By Type - Global Live Vaccines Revenue & Forecasts
4.2.1 By Type - Global Live Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Live Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Live Vaccines Revenue Market Share, 2018-2030
4.3 By Type - Global Live Vaccines Sales & Forecasts
4.3.1 By Type - Global Live Vaccines Sales, 2018-2023
4.3.2 By Type - Global Live Vaccines Sales, 2024-2030
4.3.3 By Type - Global Live Vaccines Sales Market Share, 2018-2030
4.4 By Type - Global Live Vaccines Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live Vaccines Market Size, 2022 & 2030
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Live Vaccines Revenue & Forecasts
5.2.1 By Application - Global Live Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Live Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Live Vaccines Revenue Market Share, 2018-2030
5.3 By Application - Global Live Vaccines Sales & Forecasts
5.3.1 By Application - Global Live Vaccines Sales, 2018-2023
5.3.2 By Application - Global Live Vaccines Sales, 2024-2030
5.3.3 By Application - Global Live Vaccines Sales Market Share, 2018-2030
5.4 By Application - Global Live Vaccines Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Live Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Live Vaccines Revenue & Forecasts
6.2.1 By Region - Global Live Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Live Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Live Vaccines Revenue Market Share, 2018-2030
6.3 By Region - Global Live Vaccines Sales & Forecasts
6.3.1 By Region - Global Live Vaccines Sales, 2018-2023
6.3.2 By Region - Global Live Vaccines Sales, 2024-2030
6.3.3 By Region - Global Live Vaccines Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Live Vaccines Revenue, 2018-2030
6.4.2 By Country - North America Live Vaccines Sales, 2018-2030
6.4.3 US Live Vaccines Market Size, 2018-2030
6.4.4 Canada Live Vaccines Market Size, 2018-2030
6.4.5 Mexico Live Vaccines Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Live Vaccines Revenue, 2018-2030
6.5.2 By Country - Europe Live Vaccines Sales, 2018-2030
6.5.3 Germany Live Vaccines Market Size, 2018-2030
6.5.4 France Live Vaccines Market Size, 2018-2030
6.5.5 U.K. Live Vaccines Market Size, 2018-2030
6.5.6 Italy Live Vaccines Market Size, 2018-2030
6.5.7 Russia Live Vaccines Market Size, 2018-2030
6.5.8 Nordic Countries Live Vaccines Market Size, 2018-2030
6.5.9 Benelux Live Vaccines Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Live Vaccines Revenue, 2018-2030
6.6.2 By Region - Asia Live Vaccines Sales, 2018-2030
6.6.3 China Live Vaccines Market Size, 2018-2030
6.6.4 Japan Live Vaccines Market Size, 2018-2030
6.6.5 South Korea Live Vaccines Market Size, 2018-2030
6.6.6 Southeast Asia Live Vaccines Market Size, 2018-2030
6.6.7 India Live Vaccines Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Live Vaccines Revenue, 2018-2030
6.7.2 By Country - South America Live Vaccines Sales, 2018-2030
6.7.3 Brazil Live Vaccines Market Size, 2018-2030
6.7.4 Argentina Live Vaccines Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Vaccines Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Live Vaccines Sales, 2018-2030
6.8.3 Turkey Live Vaccines Market Size, 2018-2030
6.8.4 Israel Live Vaccines Market Size, 2018-2030
6.8.5 Saudi Arabia Live Vaccines Market Size, 2018-2030
6.8.6 UAE Live Vaccines Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Live Vaccines Major Product Offerings
7.1.4 Merck Live Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Live Vaccines Major Product Offerings
7.2.4 GlaxoSmithKline Live Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Live Vaccines Major Product Offerings
7.3.4 Pfizer Live Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Live Vaccines Major Product Offerings
7.4.4 Novartis Live Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Astellas Pharma
7.5.1 Astellas Pharma Company Summary
7.5.2 Astellas Pharma Business Overview
7.5.3 Astellas Pharma Live Vaccines Major Product Offerings
7.5.4 Astellas Pharma Live Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Astellas Pharma Key News & Latest Developments
7.6 Emergent BioSolutions
7.6.1 Emergent BioSolutions Company Summary
7.6.2 Emergent BioSolutions Business Overview
7.6.3 Emergent BioSolutions Live Vaccines Major Product Offerings
7.6.4 Emergent BioSolutions Live Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Emergent BioSolutions Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Live Vaccines Major Product Offerings
7.7.4 AstraZeneca Live Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
8 Global Live Vaccines Production Capacity, Analysis
8.1 Global Live Vaccines Production Capacity, 2018-2030
8.2 Live Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Vaccines Supply Chain Analysis
10.1 Live Vaccines Industry Value Chain
10.2 Live Vaccines Upstream Market
10.3 Live Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
